NCT01206088
- Conditions
- CML, Imatinib Intolerant, Imatinib Resistant, +1 more
- Locations
-
- St. Mary hospital, Catholic medical center Seoul, South Korea
Clinical trial condition
Explore clinical trials studying Nilotinib. Study availability and eligibility vary by location and protocol.
NCT01206088